Combined Treatment with Host-Directed and Anticytomegaloviral Kinase Inhibitors: Mechanisms, Synergisms and Drug Resistance Barriers
Despite the availability of currently approved antiviral drugs, Solid Ink infections with human cytomegalovirus (HCMV) still cause clinically challenging, sometimes life-threatening situations.There is an urgent need for enhanced anti-HCMV drugs that offer improved efficacy, reduced dosages and options for long-term treatment without risk of the de